Literature DB >> 15217949

N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.

Sanae Nakajima1, Ryuichiro Doi, Eiji Toyoda, Shoichiro Tsuji, Michihiko Wada, Masayuki Koizumi, Sidhartha S Tulachan, Daisuke Ito, Kazuhiro Kami, Tomohiko Mori, Yoshiya Kawaguchi, Koji Fujimoto, Ryo Hosotani, Masayuki Imamura.   

Abstract

PURPOSE: Loss of intercellular adhesion and increased cell motility promote tumor cell invasion. In the present study, E- and N-cadherin, members of the classical cadherin family, are investigated as inducers of epithelial-to-mesenchymal transition (EMT) that is thought to play a fundamental role during the early steps of invasion and metastasis of carcinomas. Cell growth factors are known to regulate cell adhesion molecules. The purpose of the study presented here was to investigate whether a gain in N-cadherin in pancreatic cancer is involved in the process of metastasis via EMT and whether its expression is affected by growth factors. EXPERIMENTAL
DESIGN: We immunohistochemically examined the expression of N- and E-cadherins and vimentin, a mesenchymal marker, in pancreatic primary and metastatic tumors. Correlations among the expressions of N-cadherin, transforming growth factor (TGF)beta, and fibroblast growth factor 2 was evaluated in both tumors, and the induction of cadherin and vimentin by growth factors was examined in cultured cell lines.
RESULTS: N-cadherin expression was observed in 13 of 30 primary tumors and in 8 of 15 metastatic tumors. N-cadherin expression correlated with neural invasion (P = 0.008), histological type (P = 0.043), fibroblast growth factor expression in primary tumors (P = 0.007), and TGF expression (P = 0.004) and vimentin (P = 0.01) in metastatic tumors. Vimentin, a mesenchymal marker, was observed in a few cancer cells of primary tumor but was substantially expressed in liver metastasis. TGF stimulated N-cadherin and vimentin protein expression and decreased E-cadherin expression of Panc-1 cells with morphological change.
CONCLUSION: This study provided the morphological evidence of EMT in pancreatic carcinoma and revealed that overexpression of N-cadherin is involved in EMT and is affected by growth factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217949     DOI: 10.1158/1078-0432.CCR-0578-03

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  167 in total

1.  Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.

Authors:  Shyamal Dilhan Weeraratne; Vladimir Amani; Natalia Teider; Jessica Pierre-Francois; Dominic Winter; Min Jeong Kye; Soma Sengupta; Tenley Archer; Marc Remke; Alfa H C Bai; Peter Warren; Stefan M Pfister; Judith A J Steen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2012-03-10       Impact factor: 17.088

Review 2.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

3.  Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.

Authors:  Woo Hyun Paik; Ji Kon Ryu; Kyoung-Sin Jeong; Jin Myung Park; Byeong Jun Song; Sang Hyub Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

4.  Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes.

Authors:  Pablo R Moya; Nicholas H Dodman; Kiara R Timpano; Liza M Rubenstein; Zaker Rana; Ruby L Fried; Louis F Reichardt; Gary A Heiman; Jay A Tischfield; Robert A King; Marzena Galdzicka; Edward I Ginns; Jens R Wendland
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

5.  Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Authors:  Vindhya Palagani; Mona El Khatib; Uta Kossatz; Przemyslaw Bozko; Martin R Müller; Michael P Manns; Till Krech; Nisar P Malek; Ruben R Plentz
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

Review 6.  Collagen XV: exploring its structure and role within the tumor microenvironment.

Authors:  Anthony George Clementz; Ann Harris
Journal:  Mol Cancer Res       Date:  2013-09-16       Impact factor: 5.852

7.  miR-197-3p reduces epithelial-mesenchymal transition by targeting ABCA7 in ovarian cancer cells.

Authors:  Weiquan Xie; Chengyu Shui; Xiping Fang; Yuqiu Peng; Li Qin
Journal:  3 Biotech       Date:  2020-08-04       Impact factor: 2.406

8.  Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.

Authors:  Nannan Lv; Zhongyan Shan; Yun Gao; Haixia Guan; Chenling Fan; Hong Wang; Weiping Teng
Journal:  Endocrine       Date:  2015-08-20       Impact factor: 3.633

9.  Breast carcinoma metastasis in recurrent myxoid liposarcoma.

Authors:  Fevziye Kabukcuoglu; Yavuz Kabukcuoglu; Canan Tanik; Damlanur Sakiz; Semra Karsidag
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

10.  Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.

Authors:  Kelly J Gordon; Kellye C Kirkbride; Tam How; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2008-12-04       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.